Favipiravir is contraindicated in the following patients: Women known or suspected to be pregnant (Early embryonic deaths and teratogenicity have been observed in animal studies. [See Use in Pregnancy & Lactation]).
Patients with a history of hypersensitivity to any ingredient of the drug.